EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Orchestration of kaempferol nuclear translocation by phase ii metabolic enzymes and efflux transporters suppresses colorectal cancer

Chishun Zhou, Qing Ning, Xin Jin, Yu Li, Yuefang Lin, Jiarun Lin, Jing Zheng, Yukai Huang, Wei Wang, Zhongqiu Liu, Linlin Lu iD

PLOS One · 2026

DOI: 10.1371/journal.pone.0355962 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Chishun Zhou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Chinese Medicine Guangdong Laboratory (Hengqin Laboratory), Guangdong Hengqin, China; and Guangdong Provincial Key Laboratory of Translational Chines…. Hauptthemen laut MEDLINE: Kaempferols, Colorectal Neoplasms, Glucuronosyltransferase, Cell Nucleus. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Open Project of the State Key Laboratory of Dampness Syndrome of Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kaempferol exhibits promising anti-colorectal cancer (CRC) activity, but its intracellular exposure and efficacy are strongly influenced by phase II metabolism and efflux transport. Here, we show that UGT1A1 and UGT1A9 differentially regulate kaempferol accumulation and anti-CRC activity, and that ABCG2/BCRP and Mdr1/P-gP play distinct roles in its intracellular retention and pharmacological effects. Anti-CRC activity was evaluated using sulforhodamine B, colony formation, wound-healing, Transwell, apoptosis, and xenograft assays. Knockdown models of UGT1A1/UGT1A9 and BCRP/P-gP were combined with laser scanning confocal microscopy and LC/MS to characterize intracellular exposure, metabolite disposition, and functional consequences. SIP-based proteomics, bioinformatic analyses, molecular docking, and orthogonal validation assays were used to prioritize and validate a nuclear target of kaempferol. Kaempferol significantly suppressed tumour growth and inhibited CRC cell proliferation and migration. UGT1A1 knockdown increased intracellular accumulation of kaempferol, including nuclear exposure, but reduced cytotoxicity, whereas UGT1A9 knockdown enhanced cellular sensitivity. Similarly, BCRP knockdown increased intracellular accumulation and anti-CRC efficacy, whereas Mdr1 knockdown attenuated the antitumour effect despite increasing total intracellular accumulation. Mechanistically, these differential effects were associated with altered metabolite composition, particularly the balance between the active metabolite K-7-G and the weakly active metabolite K-3-G. BRG1 was prioritized as a functionally relevant nuclear target of kaempferol, and kaempferol promoted its ubiquitination-dependent proteasomal degradation. Together, these findings show that kaempferol efficacy is determined not simply by intracellular accumulation, but by the coordinated interplay among phase II metabolism, efflux transport, metabolite disposition, and nuclear target engagement. This study provides a mechanistic basis for improving kaempferol-based CRC therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KaempferolsColorectal NeoplasmsGlucuronosyltransferaseCell NucleusNeoplasm ProteinsHumansAnimalsCell Line, TumorUGT1A1 EnzymeUDP-Glucuronosyltransferase 1A9MiceCell ProliferationMice, NudeATP Binding Cassette Transporter, Subfamily G, Member 2Active Transport, Cell NucleusCell Movement

Substanzen

KaempferolskaempferolGlucuronosyltransferaseUGT1A1 EnzymeUDP-Glucuronosyltransferase 1A9UGT1A9 protein, humanNeoplasm ProteinsATP Binding Cassette Transporter, Subfamily G, Member 2

Autor:innen und Institutionen

  • Chinese Medicine Guangdong Laboratory (Hengqin Laboratory), Guangdong Hengqin, China; and Guangdong Provincial Key Laboratory of Translational Chinese Medicine, Joint International Research Laboratory of Translational C…
  • Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
  • Department of Colorectal Surgery, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Clinical Research Academy of Chinese Medicine, Guangzhou, China.
  • Department of Gastrointestinal Surgery, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Clinical Research Academy of Chinese Medicine, Guangzhou, China.

ORCID-Profile: Linlin Lu

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Open Project of the State Key Laboratory of Dampness Syndrome of Chinese Medicine
  • State Key Laboratory of Traditional Chinese Medicine Syndrome
  • Incubation Program for Science and Technology Development of the Guangdong Laboratory of Chinese Medicine
  • Guangdong Provincial Talent Support Project
  • National TCM inheritance and innovation project

Zitieren

APA

Zhou, C., Ning, Q., Jin, X., Li, Y., Lin, Y., Lin, J., Zheng, J., Huang, Y., Wang, W., Liu, Z., & Lu, L. (2026). Orchestration of kaempferol nuclear translocation by phase ii metabolic enzymes and efflux transporters suppresses colorectal cancer. PLOS One. https://doi.org/10.1371/journal.pone.0355962

Vancouver

Zhou C, Ning Q, Jin X, Li Y, Lin Y, Lin J, et al. Orchestration of kaempferol nuclear translocation by phase ii metabolic enzymes and efflux transporters suppresses colorectal cancer. PLOS One. 2026. doi:10.1371/journal.pone.0355962

BibTeX
@article{Zhou2026,
  author = {Zhou, Chishun and Ning, Qing and Jin, Xin and Li, Yu and Lin, Yuefang and Lin, Jiarun and Zheng, Jing and Huang, Yukai and Wang, Wei and Liu, Zhongqiu and Lu, Linlin},
  title = {Orchestration of kaempferol nuclear translocation by phase ii metabolic enzymes and efflux transporters suppresses colorectal cancer},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0355962}
}
Kostenlos starten →